Add to ORKGMy impression is that explicit data on the cost-effectiveness of different health care services are not valued highly by US policy makers. An example is a recent decision to approve ipilimumab for the treatment of metastatic melanoma. The extra health benefit over standard treatment is 2.1 months in previously untreated patients and the cost is $120,000 for 4 doses. This is poor value for money. Had $120,000 been allocated to an intensive lifestyle modification programme for diabetes risk (Diabet Med. 2004 Nov;21(11):1229-36) then 67 years of life or 800 months could have been returned. A massive increase in health benefits for the same costs
AbstractHealthcare delivery in the USA and abroad has changed dramatically over the last several dec...
ImportanceIncreasingly, cost-effectiveness analyses are being done to determine the value of rapidly...
There is a growing recognition that we cannot afford the provision of all new health care technologi...
My impression is that explicit data on the cost-effectiveness of different health care services are ...
The United States spends more of its gross domestic product on health care than any other industrial...
Are we getting the most health improvement possible for our money. In other words, are all the thing...
In an effort to control rising drug costs, some health insurers have begun experimenting with method...
In this issue, Owens and colleagues (1) claim that the goalof policy should be to “preserve the deli...
The major expansion of federal comparative effectiveness research launched in 2009 held the potentia...
Abstract: Cost-effectiveness analyses (CEA) employ rigorous methods to help payers and governments a...
Concerns are often expressed about the failure of health care decision-makers at different levels of...
TO THE EDITOR: Garber (1) and Wilensky (2) both recognize the importance of information about compar...
Are we getting the most health improvement possible for our money. In other words, are all the thing...
Although the U.S. spends more on medical care than any country in the world, Americans live shorter ...
Health care costs in the United States are increasing unsustainably, and further efforts to control ...
AbstractHealthcare delivery in the USA and abroad has changed dramatically over the last several dec...
ImportanceIncreasingly, cost-effectiveness analyses are being done to determine the value of rapidly...
There is a growing recognition that we cannot afford the provision of all new health care technologi...
My impression is that explicit data on the cost-effectiveness of different health care services are ...
The United States spends more of its gross domestic product on health care than any other industrial...
Are we getting the most health improvement possible for our money. In other words, are all the thing...
In an effort to control rising drug costs, some health insurers have begun experimenting with method...
In this issue, Owens and colleagues (1) claim that the goalof policy should be to “preserve the deli...
The major expansion of federal comparative effectiveness research launched in 2009 held the potentia...
Abstract: Cost-effectiveness analyses (CEA) employ rigorous methods to help payers and governments a...
Concerns are often expressed about the failure of health care decision-makers at different levels of...
TO THE EDITOR: Garber (1) and Wilensky (2) both recognize the importance of information about compar...
Are we getting the most health improvement possible for our money. In other words, are all the thing...
Although the U.S. spends more on medical care than any country in the world, Americans live shorter ...
Health care costs in the United States are increasing unsustainably, and further efforts to control ...
AbstractHealthcare delivery in the USA and abroad has changed dramatically over the last several dec...
ImportanceIncreasingly, cost-effectiveness analyses are being done to determine the value of rapidly...
There is a growing recognition that we cannot afford the provision of all new health care technologi...